Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8
|
pubmed:dateCreated |
1993-2-8
|
pubmed:abstractText |
The antibody response of mice infected with Plasmodium vinckei after treatment with chloroquine either alone or in combination with interferon-gamma (IFN-gamma) was determined. Sequential serum samples were drawn from BALB/c mice receiving either 240 micrograms chloroquine on the day of infection or 120 micrograms chloroquine plus 10(4) units IFN-gamma daily for 11 days beginning on day 3 prior to infection. Mice treated with additional IFN-gamma showed an early induction of IgG2a response and a reduction in IgG1 antibodies as detected by the immunofluorescence technique at between 10 and 16 days after infection as compared with mice treated with chloroquine alone. Thus, IFN-gamma may partly exert its antimalarial activity via the induction of IgG2a antibody formation. At 4-6 weeks after infection, when mice from both groups resisted homologous re-infection, the predominant antibody isotypes found in both groups were IgG1 and IgG2a. Serum samples obtained from mice in both treatment groups at 6 weeks after infection were used for serum transfer experiments. When parasitised erythrocytes were preincubated with such immune serum, a retardation of the course of parasitaemia by 2 days was observed.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Protozoan,
http://linkedlifedata.com/resource/pubmed/chemical/Chloroquine,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin G,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin M,
http://linkedlifedata.com/resource/pubmed/chemical/Interferon-gamma,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0932-0113
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
78
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
629-34
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:1480597-Animals,
pubmed-meshheading:1480597-Antibodies, Protozoan,
pubmed-meshheading:1480597-Chemotherapy, Adjuvant,
pubmed-meshheading:1480597-Chloroquine,
pubmed-meshheading:1480597-Female,
pubmed-meshheading:1480597-Fluorescent Antibody Technique,
pubmed-meshheading:1480597-Immunization, Passive,
pubmed-meshheading:1480597-Immunoblotting,
pubmed-meshheading:1480597-Immunoglobulin G,
pubmed-meshheading:1480597-Immunoglobulin M,
pubmed-meshheading:1480597-Interferon-gamma,
pubmed-meshheading:1480597-Malaria,
pubmed-meshheading:1480597-Mice,
pubmed-meshheading:1480597-Plasmodium,
pubmed-meshheading:1480597-Recombinant Proteins
|
pubmed:year |
1992
|
pubmed:articleTitle |
Antibody response in Plasmodium vinckei malaria after treatment with chloroquine and adjuvant interferon-gamma.
|
pubmed:affiliation |
Landesinstitut für Tropenmedizin Berlin, Federal Republic of Germany.
|
pubmed:publicationType |
Journal Article
|